Neuropsychiatric Review

Cognitive Deficits in
Bipolar Disorder

Bipolar disorder is associated with pervasive neurocognitive impairments that persist across mood states. These deficits affect daily functioning independently of mood symptoms and are increasingly recognized as a core feature of the illness.

~40%
of patients show clinically significant cognitive impairment, even during remission
0.5 SD
average effect size below healthy controls across most cognitive domains
6+
distinct cognitive domains consistently affected across studies
Domain Profile

Severity by Cognitive Domain

DomainEffect Size vs. Healthy Controls (Cohen's d)Severity
Verbal Learning & Memory
Recall of word lists, stories, passages
0.64 d
Executive Function
Planning, cognitive flexibility, inhibition
0.59 d
Attention & Concentration
Sustained and selective attention tasks
0.57 d
Processing Speed
Mental processing efficiency, reaction time
0.54 d
Working Memory
Short-term storage and manipulation of information
0.50 d
Visual-Spatial Memory
Recall of designs, spatial locations
0.42 d
Premorbid IQ
Estimated intellectual ability prior to onset
0.30 d
Large (d ≥ 0.8)
Moderate (d 0.5–0.79)
Small–moderate (d 0.3–0.49)
Small (d < 0.3)
Mood State

Cognitive Profile Across Illness Phases

Manic Episode

Mania

  • Severe attention & distractibility deficits
  • Impaired impulse control and inhibition
  • Poor insight and judgment
  • Working memory markedly reduced
  • Risk-taking and decision-making impaired
  • Subjective sense of enhanced cognition
Depressive Episode

Depression

  • Slowed processing speed (psychomotor slowing)
  • Impaired sustained attention
  • Negative bias in memory encoding
  • Executive function significantly reduced
  • Poor verbal fluency and word retrieval
  • Greatest functional impairment seen here
Euthymia (Remission)

Euthymia

  • Deficits persist despite mood stability
  • Verbal memory most consistently impaired
  • Mild-to-moderate executive dysfunction
  • Processing speed remains slowed
  • Trait marker, not purely state-dependent
  • Predicts functional outcomes and relapse
Comparison

Bipolar Disorder vs. Schizophrenia

Domain
Bipolar Disorder
Schizophrenia
Verbal Memory
Moderate impairment (d ≈ 0.6)
Severe impairment (d ≈ 1.2)
Processing Speed
Mild–moderate (d ≈ 0.5)
Severe (d ≈ 1.5)
Executive Function
Moderate (d ≈ 0.6)
Moderate–severe (d ≈ 1.0)
Working Memory
Moderate (d ≈ 0.5)
Severe (d ≈ 1.3)
Overall Profile
Intermediate severity; similar pattern to SZ but consistently less severe across all domains
More pervasive and severe; premorbid decline more pronounced; greater heterogeneity
Moderators

Factors Influencing Cognitive Severity

⬆ Worsening Cognition

Increasing number of episodes (especially manic), longer illness duration, history of psychosis, residual mood symptoms, substance comorbidity, and older age at assessment.

⬇ Protective / Mitigating

Higher premorbid IQ, early and sustained mood stabilization, aerobic exercise, cognitive remediation therapy, and good medication adherence.

BD-I vs. BD-II

BD-I is associated with greater cognitive impairment than BD-II, likely related to more frequent and severe manic episodes causing cumulative neurobiological burden.

Medication Effects

Lithium may be modestly neuroprotective. Polypharmacy and high benzodiazepine use are associated with worse cognition. Some antipsychotics impact processing speed.

Functional Impact

Real-World Consequences

Occupational Functioning

Verbal memory and executive function are the strongest predictors of work performance and employment status, independent of mood symptoms.

Social Functioning

Theory of mind and emotion recognition deficits impair social cognition, reducing quality of relationships and social network size.

Treatment Adherence

Executive dysfunction and memory deficits contribute directly to poor medication adherence, increasing relapse risk and creating a cycle of cognitive worsening.

Independence & Daily Life

Processing speed and attention deficits affect driving, financial management, and self-care. Cognitive impairment predicts disability more than mood episodes alone.

Sources & Notes: Effect sizes represent approximate meta-analytic averages (Kurtz & Gerraty, 2009; Robinson et al., 2006; Torres et al., 2007; Bora et al., 2009). Cohen's d: small = 0.2, medium = 0.5, large = 0.8. For educational and clinical reference purposes.